Neonatal Chylothoraces: A 10-Year Experience in a Tertiary Neonatal Referral Centre

Table 1

Perinatal and neonatal characteristics, management, and outcomes.

Neonate	Birth weight (g)	Gestation (weeks)	Antenatal	Mode of delivery	Resuscitation	Diagnoses	MCT feeds	Octreotide and dose	Ventilation (days)	Outcome
1	3080	39	Normal	VD	Thick meconium intubated at 10 minutes	Acquired NC, MAS, multiple pneumothoraces	Yes	No	38	Alive
2	2252	33	Hydrops, bilateral effusions, antenatal shunts	VD	Pleural shunts clamped & intubated at birth	Congenital NC	Yes	Yes (2–8 mcg/kg/hr)	31	Alive
3	4078	38	Left pleural effusion & mediastinal shift	CS	Intubated at birth	Congenital NC	Yes	No	28	Alive
4	2790	37	Left CDH	VD	Intubated at birth	Acquired NC, CDH	Yes	Yes (1–4 mcg/kg/hr)	125	Died
5	2690	38	Polyhydramnios	VD	No resuscitation	Acquired NC, OA, TOF	Yes	Yes (1–2 mcg/kg/hr)	13	Alive
6	3350	37	Polyhydramnios	VD	No resuscitation	Acquired NC, OA, TOF	Yes	No	19	Alive

CDH: congenital diaphragmatic hernia; CS: caesarian section; MAS: meconium aspiration syndrome; MCT: medium-chain triglycerides; NC: neonatal chylothorax; OA: oesophageal atresia; TOF tracheoesophageal fistula; VD: vaginal delivery; neonate had a reduction in pleural output following introduction of MCT feeds; octreotide was given prior to surgical intervention.